fromInside Higher Ed | Higher Education News, Events and Jobs
12 hours agoBiotech to "Shift to U.K. and China" After U.S. mRNA Cuts
Paul Hunter, professor of medicine at the University of East Anglia, said other countries with active biotechnology industries will benefit, but the decision will still delay the development of new vaccines worldwide. "Progress will continue but not as quickly as otherwise. Lives will be lost that could have been saved had there been a vaccine," he told Times Higher Education.
US politics